222 related articles for article (PubMed ID: 16149873)
1. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Frick GS; Pitari GM; Weinberg DS; Hyslop T; Schulz S; Waldman SA
Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
[TBL] [Abstract][Full Text] [Related]
2. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.
Waldman SA; Barber M; Pearlman J; Park J; George R; Parkinson SJ
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):505-14. PubMed ID: 9641495
[TBL] [Abstract][Full Text] [Related]
4. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
5. Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells.
Buc E; Vartanian MD; Darcha C; Déchelotte P; Pezet D
Eur J Cancer; 2005 Jul; 41(11):1618-27. PubMed ID: 15919201
[TBL] [Abstract][Full Text] [Related]
6. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Birbe R; Palazzo JP; Walters R; Weinberg D; Schulz S; Waldman SA
Hum Pathol; 2005 Feb; 36(2):170-9. PubMed ID: 15754294
[TBL] [Abstract][Full Text] [Related]
7. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients.
Bustin SA; Gyselman VG; Williams NS; Dorudi S
Br J Cancer; 1999 Apr; 79(11-12):1813-20. PubMed ID: 10206298
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
9. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
Carrithers SL; Barber MT; Biswas S; Parkinson SJ; Park PK; Goldstein SD; Waldman SA
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14827-32. PubMed ID: 8962140
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
Park J; Schulz S; Haaf J; Kairys JC; Waldman SA
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):739-44. PubMed ID: 12163327
[TBL] [Abstract][Full Text] [Related]
11. Previstage GCC test for staging patients with colorectal cancer.
Mejia A; Waldmana SA
Expert Rev Mol Diagn; 2008 Sep; 8(5):571-8. PubMed ID: 18785805
[TBL] [Abstract][Full Text] [Related]
12. Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications.
Kong SL; Salto-Tellez M; Leong AP; Chan YH; Koay ES
J Clin Pathol; 2005 Aug; 58(8):839-44. PubMed ID: 16049286
[TBL] [Abstract][Full Text] [Related]
13. Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer.
Carlson MR
Mol Diagn Ther; 2009; 13(1):11-4. PubMed ID: 19351210
[TBL] [Abstract][Full Text] [Related]
14. Molecular signature detection of circulating tumor cells using a panel of selected genes.
Gervasoni A; Monasterio Muñoz RM; Wengler GS; Rizzi A; Zaniboni A; Parolini O
Cancer Lett; 2008 May; 263(2):267-79. PubMed ID: 18262345
[TBL] [Abstract][Full Text] [Related]
15. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
18. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
19. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
Waldman SA; Cagir B; Rakinic J; Fry RD; Goldstein SD; Isenberg G; Barber M; Biswas S; Minimo C; Palazzo J; Park PK; Weinberg D
Dis Colon Rectum; 1998 Mar; 41(3):310-5. PubMed ID: 9514425
[TBL] [Abstract][Full Text] [Related]
20. Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Beaulieu M; Desaulniers M; Bertrand N; Deschesnes RG; Beaudry G; Garon G; Haince JF; Houde M; Holzer TJ
Diagn Mol Pathol; 2010 Mar; 19(1):20-7. PubMed ID: 20186008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]